NEI Research News

Research funded by the National Eye Institute suggests that low density of pigment in the macula, the region of the retina required for sharp central vision, is associated with thinning of the retina and may serve as an early warning sign of glaucoma.

Using atomic force microscopy, researchers at Doheny Eye Institute, an affiliate of University of California Los Angeles, discovered retinal capillary stiffening in diabetic mice that is causally linked to the development of retinopathy

NEI Director Michael F. Chiang featured recent research by NEI grantee Louis Pasquale, Mount Sinai, in an NIH Director’s Blog post.

A longstanding member of the NEI/NIH community, Emily Chew, M.D., has been promoted to the title of NIH Distinguished Investigator for her tireless and prolific work as a care provider and clinical trialist.

David Williams, Donald Miller, and Austin Roorda, received recognition for the development of instruments that use adaptive optics technologies to capture high-resolution images of the retina.

A multidisciplinary team led by researchers at the Schepens Eye Research Institute of Mass Eye and Ear has identified a promising new strategy for glaucoma cell replacement therapy.

The discovery will enable researchers to better understand eye movement disorders that cause significant visual impairment.

All of Us is assembling a large-cohort dataset of at least 1 million participants who reflect the diversity of the U.S. population.

NEI-funded investigators at Washington University in St. Louis discovered a potential new treatment approach to diabetic retinopathy, one of the most common causes of vision loss in the U.S.

In primates, activity in the visual cortex—a part of the brain that processes signals from the eyes—is largely unaffected by the body’s own movements, according to a new study from scientists at the National Eye Institute (NEI).